Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
Crossref DOI link: https://doi.org/10.1186/s12967-014-0294-y
Published Online: 2014-11-13
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kwilas, Anna R
Ardiani, Andressa
Donahue, Renee N
Aftab, Dana T
Hodge, James W
License valid from 2014-11-13
Article History
Received: 10 September 2014
Accepted: 9 October 2014
First Online: 13 November 2014